Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007;67(16):2433-72.
doi: 10.2165/00003495-200767160-00008.

Celecoxib: A Review of Its Use in the Management of Arthritis and Acute Pain

Affiliations
Review

Celecoxib: A Review of Its Use in the Management of Arthritis and Acute Pain

James E Frampton et al. Drugs. .

Abstract

Celecoxib (Celebrex), the first cyclo-oxygenase (COX) 2-selective inhibitor (coxib) to be introduced into clinical practice, has been available for almost a decade. It is approved in one or more countries worldwide for the relief of the signs and symptoms of osteoarthritis (OA), rheumatoid arthritis (RA), juvenile rheumatoid arthritis (in patients aged > or =2 years) and ankylosing spondylitis (AS), the management of acute pain in adults, the treatment of primary dysmenorrhoea and the reduction in the number of adenomatous colorectal polyps in familial adenomatous polyposis. Celecoxib remains an effective and useful altenative to nonselective NSAIDs in the treatment of acute or chronic musculoskeletal pain. In the latter setting, it offers the prospect of improved gastrointestinal (GI) tolerability and, in patients not taking aspirin for cardioprophylaxis, a GI safety advantage. Currently available evidence of an increase in cardiovascular (CV) risk with celecoxib is inconsistent; any increase in risk is likely to be small and similar to that with nonselective NSAIDs. As with all NSAIDs, the potential GI, CV and renal risks of celecoxib must be weighed against the potential benefits in each individual; it is a rational choice for patients at low CV risk who require NSAID therapy, especially those at increased risk of NSAID-induced GI toxicity, but also those unresponsive to, or intolerant of, other NSAIDs. If selected, celecoxib, like all NSAIDs, should be used at the lowest effective dose for the shortest possible duration.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

References

    1. BMJ. 2002 Sep 21;325(7365):619 - PubMed
    1. J Int Med Res. 2003 Mar-Apr;31(2):102-12 - PubMed
    1. Anesth Analg. 2007 Jul;105(1):228-32 - PubMed
    1. Arthritis Rheum. 2007 Jun 15;57(5):748-55 - PubMed
    1. Pharmacotherapy. 2001 Oct;21(10):1223-32 - PubMed

MeSH terms

LinkOut - more resources

Feedback